OncoSil Medical Ltd News

OncoSil Medical Ltd Updates Corporate Constitution

TipRanksNov 29 16:57

OncoSil Medical Signs Exclusive Distribution Agreements in Nordics Region, Egypt

MT NewswiresNov 18 12:13

OncoSil Medical Secures Distribution Deal for Pancreatic Cancer Therapy in Middle East; Shares Drop 7%

MT NewswiresOct 7 09:35

OncoSil Medical Ltd: Annual Report Differences to Appendix 4E

ASXSep 30 17:04 · Announcements

OncoSil Medical Ltd: Annual Report

ASXSep 30 16:54 · Announcements

OncoSil Medical Ltd: Appendix 4E Preliminary Financial Report

Aug 30 06:59 · Announcements

OncoSil's Commercial Treatment Sales Surge 78% in Fiscal Q4; Shares Up 10%

MT NewswiresAug 15 11:14

OncoSil Medical Ltd Announces Capital Raising

TipRanksAug 7 08:19

OncoSil Medical Gets AU$2.7 Million Investment for Building Distribution Network

MT NewswiresJul 25 13:17

OncoSil Medical Treats Fifth Pancreatic Cancer Patient With Proprietary Device

MT NewswiresJun 11 08:09

Oncosil Medical Treats 200th Pancreatic Cancer Patient With Proprietary Device

MT NewswiresJun 3 09:07

Oncosil Medical Enters Distribution Agreement With Abdulla Fouad Group for Saudi Arabia

MT NewswiresMay 23 08:47

OncoSil Medical Raises AU$5.3 Million Under Entitlement Offer

MT NewswiresMay 2 09:42

OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial

MT NewswiresApr 18 06:52

OncoSil Medical Treats First Commercial Patient in Turkey With Implantable Pancreatic Cancer Device

MT NewswiresApr 16 08:53

OncoSil Medical Treats First UK Patient for Pancreatic Cancer Study

MT NewswiresApr 12 11:29

OncoSil Medical Obtains Device Reimbursement Approval in UK

MT NewswiresApr 9 10:19

First Austria-Based Patients Treated Using OncoSil Pancreatic Cancer Device

MT NewswiresApr 5 06:52

Oncosil Medical Issues Non-Renounceable Entitlement Offer Prospectus

MT NewswiresMar 25 08:40

Oncosil Medical to Raise Over AU$7 Million via Placement, Entitlement Offer

MT NewswiresMar 20 11:02